{
  "abstract": "Background: Patients with advanced hepatocellular carcinoma (HCC) under treatment with tyrosine kinase inhibitors (TKI) are at greater risk for gastrointestinal variceal bleeding. This risk in part due to cirrhosis and portal hypertension and in part due to effect of TKI on vascular endothelial growth factor pathway. Aim: to study baseline factors associated with variceal bleeding risk in HCC patients subjected to treatment by TKI. Methods: Patients with advanced HCC treated with TKI in Faculty of Medicine Ain Shams Research Institute (MASRI) during period from May 2024 to May 2025 were evaluated in this observational cohort study performed in Ain Shams University. Baseline characteristics and laboratory investigation were collected, and all patients underwent endoscopic assessment before enrollment in the study and were followed for 6 months. Variceal bleeding episodes were recorded. Results: among 186 patients evaluated, 170 patients were included (46 included prospectively and 124 retrospectively). Patients were followed for 6 months after date of inclusion of last patient. Mean age of participants was 62.7 ± 7.7 years and 75.9% were males. 13 patients developed variceal bleeding attacks during follow up period, all of them had high risk variceal features in baseline endoscopy. Malignant portal vein thrombosis appears to correlate with risk of bleeding and patients who were able to tolerate nonselective beta blockers (NSBB) (carvedilol) appear to have lower variceal bleeding risk. Conclusions: although results showed beneficial effect for carvedilol, prospective larger studies are needed to confirm if nonselective beta blockers had protective effect in this group of patients.",
  "abstract_shown": true,
  "affiliations": [
    "Tropical Medicine Department. Faculty of Medicine. Ain Shams university",
    "Department of Internal Medicine, Faculty of Medicine, Ain-Shams university, Cairo, Egypt",
    "Tropical Medicine Department. Faculty of Medicine, Ain Shams University",
    "Internal Medicine Department, Faculty of Medicine, Ain Shams University",
    "Tropical Medicine Department, Faculty of Medicine, Ain Shams University"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Mohamed Salaheldin"
    },
    {
      "affs": [
        1
      ],
      "name": "Mohamed Fouad"
    },
    {
      "affs": [
        2
      ],
      "name": "Heba Aly"
    },
    {
      "affs": [
        3
      ],
      "name": "Marwa Mohamed"
    },
    {
      "affs": [
        4
      ],
      "name": "Mostafa Shamakh"
    },
    {
      "affs": [
        4
      ],
      "name": "Dina Fathy"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/3yg49vka9fxtc.bib",
  "cited_by": 0,
  "doi": "10.21608/asmj.2026.522689.1701",
  "fulltext_url": "https://asmj.journals.ekb.eg/article_538908.html",
  "id": "3yg49vka9fxtc",
  "issns": [
    "2735-3540",
    "0002-2144"
  ],
  "landing_url": "https://doi.org/10.21608/asmj.2026.522689.1701",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "R"
    ],
    [
      "openalex",
      "2721|Hepatocellular Carcinoma Treatment and Prognosis"
    ]
  ],
  "openalex": "W7225792981",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-15",
  "publisher": "Ain Shams University; Faculty of Medicine. Ain Shams Clinical and Scientific Society",
  "ris": "https://research.draconitic.com/paper/3yg49vka9fxtc.ris",
  "sources": [
    {
      "first_seen": "2026-11-15T15:20:52Z",
      "native_id": "0ba85e210b26420781e9b7f5f781ea28",
      "source": "doaj",
      "url": "https://doi.org/10.21608/asmj.2026.522689.1701"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2721|Hepatocellular Carcinoma Treatment and Prognosis",
      "subfield": "general"
    }
  ],
  "title": "Factors Associated with Variceal bleeding in patients with advanced hepatocellular carcinoma treated with Sorafenib or Regorafenib",
  "title_text": "Factors Associated with Variceal bleeding in patients with advanced hepatocellular carcinoma treated with Sorafenib or Regorafenib",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T15:20:49Z",
  "url": "https://research.draconitic.com/paper/3yg49vka9fxtc",
  "venue": "Ain Shams Medical Journal",
  "versions": []
}